Unexpected Consequences of Insulin Resistance for the Heart
胰岛素抵抗对心脏的意外后果
基本信息
- 批准号:8985384
- 负责人:
- 金额:$ 24.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-02-01 至 2018-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAttenuatedAwardBiochemicalCalciumCardiacCardiovascular DiseasesCardiovascular systemCellsCessation of lifeChemicalsChronicCoronary arteryDevelopmentDiabetes MellitusEnergy MetabolismEnergy-Generating ResourcesEnsureEventFailureFatty AcidsFatty acid glycerol estersFunctional disorderFutureGene ExpressionGenesGlucoseGlycolysisGoalsHeartHeart failureHepaticHexosaminesHyperglycemiaImpairmentIn VitroInsulinInsulin ResistanceInvestigationKnowledgeLaboratoriesLinkMechanicsMediatingMediator of activation proteinMentorsMetabolicMetabolismModelingMolecularMolecular BiologyMyocardialMyocardial ContractionNon-Insulin-Dependent Diabetes MellitusOrganismOxidative StressPathway interactionsPentosephosphate PathwayPerceptionPhasePhysiologicalPoisonPoisoningProcessPumpPyruvateResearchRisk FactorsSignal TransductionSkeletal MuscleStressTechniquesTestingTissuesWorkWorkloadbasebiological adaptation to stressblood glucose regulationdesensitizationdesigndisabilityexperiencefetalglucose metabolismglucose uptakeheart functionimpaired capacityimprovedinsulin signalingmitochondrial uncoupling protein 3noveloxidationprematurepressurepreventprogramsprotein degradationresponseskillstranscription factor
项目摘要
Summary
My immediate goal is to acquire the necessary skills and expertise to make a successful transition to
independence in the academic field of basic cardiovascular research. The long term goals of this work are to
advance our knowledge on the molecular mechanisms that control glucose and fatty acid utilization in the
heart. Premature death and disability from cardiovascular diseases are dire complications in diabetes.
Diabetes is associated with high circulating levels of glucose and fatty acids, which are both energy providing
substrates for the heart. Like other insulin-responsive tissues in the organism, the heart in diabetes becomes
insulin resistant. Because impaired glucose uptake in response to insulin is the main feature of myocardial
insulin resistance (MIR), I propose that MIR is part of an adaptive program with which the heart protects
itself from the hyperglycemic milieu of diabetes mellitus. The rationale arises from the observation that
increased glucose supply to the heart results in rates of glucose uptake greater than rates of glucose oxidation,
the intracellular accumulation of glucose intermediates and, subsequently, contractile dysfunction. Specific
Aim 1 will determine the effects of hyperglycemia on cardiac gene expression. This aim will test the hypothesis
that the intracellular accumulation of glucose metabolites in the heart reactivates the fetal gene program, which
can be prevented by the impairment of insulin-mediated glucose uptake. Specific Aim 2 will define the effect
of MIR on energy metabolism and contractile function of the heart subjected to chronic pressure overload.
Specifically, it will test the hypothesis that MIR increases glucose oxidation while limiting glucose uptake, and
delays the transition toward failure of the stressed heart. Specific Aim 3 will seek to identify the molecular
mechanism controlling substrate selection in the stressed heart. It will test the hypothesis that the uncoupling
protein 3 (UCP3) decreases efficiency of the heart subjected to a high workload by inhibiting glucose oxidation.
These aims will be addressed by combining my experience in molecular biology to the techniques available in
the mentor’s laboratory, and will set the path to future investigations aiming to define the links between insulin
signaling and the expression of UCP3 in the heart. Collectively, the proposed work seeks to demonstrate that
MIR is more a physiological response for the stressed heart in diabetes, rather than a primary cause for heart
failure.
总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Romain Harmancey其他文献
Romain Harmancey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Romain Harmancey', 18)}}的其他基金
Molecular Basis of Postischemic Maladaptation in the Insulin Resistant Heart
胰岛素抵抗心脏缺血后适应不良的分子基础
- 批准号:
9899301 - 财政年份:2018
- 资助金额:
$ 24.07万 - 项目类别:
Molecular Basis of Postischemic Maladaptation in the Insulin Resistant Heart
胰岛素抵抗心脏缺血后适应不良的分子基础
- 批准号:
10153852 - 财政年份:2018
- 资助金额:
$ 24.07万 - 项目类别:
Molecular Basis of Postischemic Maladaptation in the Insulin Resistant Heart
胰岛素抵抗心脏缺血后适应不良的分子基础
- 批准号:
10595939 - 财政年份:2018
- 资助金额:
$ 24.07万 - 项目类别:
Unexpected Consequences of Insulin Resistance for the Heart
胰岛素抵抗对心脏的意外后果
- 批准号:
9212832 - 财政年份:2015
- 资助金额:
$ 24.07万 - 项目类别:
Unexpected Consequences of Insulin Resistance for the Heart
胰岛素抵抗对心脏的意外后果
- 批准号:
8509455 - 财政年份:2013
- 资助金额:
$ 24.07万 - 项目类别:
Unexpected Consequences of Insulin Resistance for the Heart
胰岛素抵抗对心脏的意外后果
- 批准号:
8704769 - 财政年份:2013
- 资助金额:
$ 24.07万 - 项目类别:
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 24.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 24.07万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 24.07万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 24.07万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 24.07万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 24.07万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 24.07万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 24.07万 - 项目类别:
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 24.07万 - 项目类别:
Idea to Innovation
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 24.07万 - 项目类别:
Research Grant














{{item.name}}会员




